Filing Flows

Filing Flows › Tilray Brands (TLRY) › Q1 FY27 › vs Q4 FY26

Tilray Brands (TLRY) Q1 FY27 vs Q4 FY26 (quarter over quarter)

Tilray Brands's revenue fell $24.6M (-9%) from $282M in Q4 FY26 to $257M in Q1 FY27. The biggest changes: Cannabis Segment −$15.4M (-21%); Wellness Business −$4.4M (-22%); Beverage Alcohol Business −$4.1M (-4%).

Tilray Brands, Q1 FY27: revenue $257M (+23% year over year), operating margin -9.4%, net loss $40.0M, operating cash flow −$16.5M. The chart draws each line against Q4 FY26, the increases inside each band.

Tilray Brands: what changed, Q1 FY27 vs Q4 FY26Tilray Brands: what changed, Q1 FY27 vs Q4 FY26Working capital & other$31.2MCosts & expenses−$22.5MCash used in operations−$20.8MOperating costs−$17.0MCannabis Segment−$15.4MIncome tax−$12.1MCost of revenue−$11.6MShare-based compensation−$8.3MInterest & other, net$6.6MWellness Business−$4.4M

Every line

LineQ1 FY27Q4 FY26Change%
Beverage Alcohol Business$101M$106M−$4.1M-4%
Distribution Business$84.3M$85.0M−$692K-0.8%
Cannabis Segment$56.1M$71.5M−$15.4M-21%
Wellness Business$15.3M$19.7M−$4.4M-22%
Revenue$257M$282M−$24.6M-9%
Net loss$40.0M$37.9M$2.1M+6%
Costs & expenses$297M$320M−$22.5M-7%
Operating costs$281M$298M−$17.0M-6%
Interest & other, net$14.3M$7.6M$6.6M+87%
Income tax$1.7M$13.9M−$12.1M-88%
Cost of revenue$180M$191M−$11.6M-6%
Research & development$89K$180K−$91K-51%
Sales & marketing$15.7M$13.5M$2.3M+17%
General & admin$57.6M$61.2M−$3.6M-6%
Other operating costs$28.1M$32.2M−$4.0M-13%
Operating cash sources$40.0M$37.9M$2.1M+6%
Share-based compensation$6.6M$14.9M−$8.3M-56%
Working capital & other$16.9M−$14.3M$31.2M—
Cash used in operations$16.5M$37.3M−$20.8M-56%
Net loss absorbed$40.0M$37.9M$2.1M+6%

Questions

How much did Tilray Brands's revenue grow quarter over quarter in Q1 FY27?

Tilray Brands's revenue fell $24.6M (-9%) from $282M in Q4 FY26 to $257M in Q1 FY27.

What drove Tilray Brands's revenue change in Q1 FY27?

Cannabis Segment −$15.4M (-21%); Wellness Business −$4.4M (-22%); Beverage Alcohol Business −$4.1M (-4%).

Q1 FY27 results → · Compare in the interactive Sankey →